Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals Ltd has informed BSE that its Board of Directors meeting is scheduled for May 29, 2026 at 03:00 PM. The meeting will consider and approve the Audited Financial Statements and Financial Results for the Financial Year and Quarter ended March 31, 2026. Additionally, the board will review the statement of deviation of funds pursuant to Regulation 32 of SEBI LODR Regulations. The company has also listed 'Other Incidental Matter' as an agenda item. This is a routine intimation filed under SEBI regulations to inform stakeholders in advance about the board meeting.
This announcement signals that Q4 and FY 2025-26 results will be released shortly after May 29, 2026. The statement of deviation of funds could indicate changes in the deployment of proceeds from any previous capital raise. Investors should monitor for the actual results announcement following this meeting.